Skip to main content

Table 2 Laboratory and ultrasonic data before and after SBT

From: Different effects of cardiac and diaphragm function assessed by ultrasound on extubation outcomes in difficult-to-wean patients: a cohort study

 

Respiratory failure within 48 h

Variables

RF subgroup

ES subgroup

N (cases)

29

31

Before SBT

 PH

7.45 ± 0.06

7.46 ± 0.05

 PaCO2 (mmHg)

46.4 ± 13

39.1 ± 5.1*

 PaO2/FiO2

277 ± 83

281 ± 80

 Lactic acid (mmol/l)

1.2 ± 0.6

1.1 ± 0.4

 NT-pro-BNP(pg/ml)

6519 ± 9162

1578 ± 1843*

 Pleural effusion

22 (76)

24 (77)

 LVEF (%)

57 ± 14

64 ± 9*

 E (cm/s)

92.9 ± 25.6

78.2 ± 18.4*

 E/Ea (septal)

18.2 ± 8.1

13 ± 3.8*

 E/Ea (lateral)

12.8 ± 5.1

8.4 ± 2.7†

 E/Ea (average)

14.7 ± 5.6

10.1 ± 2.8†

 DE (right) (mm)

11.2 ± 4.7

10.1 ± 4.7

 DE (left) (mm)

11.6 ± 6.3

10.8 ± 5.5

 DE (average) (mm)

11.4 ± 4.5

10.5 ± 3.4

After SBT

 PH

7.43 ± 0.05

7.47 ± 0.05*

 PaCO2 (mmHg)

48 ± 11.7

38.7 ± 5.5†

 PaO2/FiO2

291 ± 103

275 ± 79

 Lactic acid (mmol/l)

1.1 ± 0.5

1.1 ± 0.5

 NT-pro-BNP(pg/ml)

6518 [421-10,477]

1471[176-1575]*

 E (cm/s)

99.7 ± 24.3

85.1 ± 18.2*

 E/Ea (septal)

18.6 ± 6.5

13.4 ± 4.4*

 E/Ea (lateral)

14.4 ± 7.3

9.0 ± 3.0*

 E/Ea (average)

15.8 ± 6.2

10.6 ± 3.2†

 DE (right) (mm)

13.7 ± 6

11 ± 4.4

 DE (left) (mm)

13.8 ± 6.4

13 ± 5.4

 DE (average) (mm)

13.7 ± 5.4

12 ± 3.4

  1. Data are presented as median ± SD or median (IQR) or n (%). DE diaphragmatic excursion, E mitral Doppler early peak diastolic velocity, E/Ea the ratio of mitral Doppler inflow velocity to annular tissue Doppler wave velocity, ES extubation success, LVEF left ventricular ejection fraction, NT-pro-BNP N-terminal-pro-B-type natriuretic peptide, PaCO 2 arterial carbon dioxide tension, PaO 2 /FiO 2 the ratio of arterial oxygen tension to fraction of inspired oxygen, RF respiratory failure, SBT spontaneous breathing trial. * Significant at p < 0.05, and † significant at p < 0.001